The 2022 China Bioanalysis Forum Annual Conference was held from June 17^th to June 19^th. Continuing with the success from previous years, Dr. Kelly Dong, deputy chair of Bioanalysis Committee of China Pharmaceutical Association, served as the conference program chair for bioanalysis and related topics in this conference.  As a long-term sponsor for CBF events, Pharma (UPP) has actively contributed to this widely recognized scientific event. Dr. Fiona Chen from UPP project leadership team provided practical training on the approaches for biomolecule PK sample analysis. With the development of new technology, ELISpot becomes an emerging tool in bioanalysis, Cyril Xie presented UPP experience using ELISpot and other new platforms in support of COVID vaccine studies. UPP scientist Tracy shared her experience in cell-based approaches for biomolecule analysis on CBF young scientist forum and Cher presented UPP bioanalytical approaches in support of CAR-T therapy in the post exhibition.